ELEV Annual Retained Earnings
-$195.97 M
-$45.70 M-30.42%
31 December 2023
Summary:
As of January 21, 2025, ELEV annual retained earnings is -$195.97 million, with the most recent change of -$45.70 million (-30.42%) on December 31, 2023. During the last 3 years, it has fallen by -$172.82 million (-746.63%). ELEV annual retained earnings is now -3231.69% below its all-time high of -$5.88 million, reached on December 31, 2019.ELEV Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV Quarterly Retained Earnings
-$230.02 M
-$12.88 M-5.93%
30 September 2024
Summary:
As of January 21, 2025, ELEV quarterly retained earnings is -$230.02 million, with the most recent change of -$12.88 million (-5.93%) on September 30, 2024. Over the past year, it has dropped by -$23.34 million (-11.29%). ELEV quarterly retained earnings is now -893.73% below its all-time high of -$23.15 million, reached on December 31, 2020.ELEV Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.4% | -11.3% |
| 3 y3 years | -746.6% | -53.1% |
| 5 y5 years | -3231.7% | -53.1% |
ELEV Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -255.1% | at low | -316.8% | at low |
| 5 y | 5-year | -3231.7% | at low | -893.7% | at low |
| alltime | all time | -3231.7% | at low | -893.7% | at low |
Elevation Oncology Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$230.02 M(+5.9%) |
| June 2024 | - | -$217.14 M(+5.1%) |
| Mar 2024 | - | -$206.68 M(+5.5%) |
| Dec 2023 | -$195.97 M(+30.4%) | -$195.97 M(+4.2%) |
| Sept 2023 | - | -$188.07 M(+6.0%) |
| June 2023 | - | -$177.44 M(+6.0%) |
| Mar 2023 | - | -$167.32 M(+11.4%) |
| Dec 2022 | -$150.27 M | -$150.27 M(+14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$131.22 M(+42.0%) |
| June 2022 | - | -$92.39 M(+27.5%) |
| Mar 2022 | - | -$72.46 M(+31.3%) |
| Dec 2021 | -$55.19 M(+138.4%) | -$55.19 M(+21.1%) |
| Sept 2021 | - | -$45.56 M(+36.8%) |
| June 2021 | - | -$33.30 M(+17.9%) |
| Mar 2021 | - | -$28.24 M(+22.0%) |
| Dec 2020 | -$23.15 M(+293.5%) | -$23.15 M |
| Dec 2019 | -$5.88 M | - |
FAQ
- What is Elevation Oncology annual retained earnings?
- What is the all time high annual retained earnings for Elevation Oncology?
- What is Elevation Oncology annual retained earnings year-on-year change?
- What is Elevation Oncology quarterly retained earnings?
- What is the all time high quarterly retained earnings for Elevation Oncology?
- What is Elevation Oncology quarterly retained earnings year-on-year change?
What is Elevation Oncology annual retained earnings?
The current annual retained earnings of ELEV is -$195.97 M
What is the all time high annual retained earnings for Elevation Oncology?
Elevation Oncology all-time high annual retained earnings is -$5.88 M
What is Elevation Oncology annual retained earnings year-on-year change?
Over the past year, ELEV annual retained earnings has changed by -$45.70 M (-30.42%)
What is Elevation Oncology quarterly retained earnings?
The current quarterly retained earnings of ELEV is -$230.02 M
What is the all time high quarterly retained earnings for Elevation Oncology?
Elevation Oncology all-time high quarterly retained earnings is -$23.15 M
What is Elevation Oncology quarterly retained earnings year-on-year change?
Over the past year, ELEV quarterly retained earnings has changed by -$23.34 M (-11.29%)